![](/img/cover-not-exists.png)
Cost-effectiveness of fondaparinux versus enoxaparin in non-ST-elevation acute coronary syndrome in Canada (OASIS-5)
Alfonso Ross Terres, Jorge, Lozano-Ortega, G., Kendall, R., Sculpher, M. J.Volume:
15
Language:
english
Journal:
BMC Cardiovascular Disorders
DOI:
10.1186/s12872-015-0175-1
Date:
December, 2015
File:
PDF, 425 KB
english, 2015